Fund Holdings — Royalty Pharma Sub-Manager, LLC

Total Portfolio Value:
$196.27M
Total Bought:
$196.27M
Total Sold:
$0
Net Transaction:
+$196.27M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Cytokinetics, Incorporated(CYTK)0980,392+980,392$0$64.62M32.92%+$64.62M
Zenas BioPharma, Inc.(ZBIO)02,388,150+2,388,150$0$64.41M32.82%+$64.41M
Biohaven Ltd.(BHVN)02,936,507+2,936,507$0$39.20M19.97%+$39.20M
Kailera Therapeutics, Inc.(KLRA)02,455,357+2,455,357$0$28.04M14.29%+$28.04M
Page 1 of 1
Royalty Pharma Sub-Manager, LLC — 13F Holdings — Q3 2026 | TickerTrail